Medical Ghostwriting: A University-Sanctioned Sleight of Hand?

Society

Volumn 49, Issue 4, 2012, Pages 310-312

  Leo, Jonathan ^a   Lacasse, Jeffrey R ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84863110941     PISSN: 01472011     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12115-012-9552-x     Document Type: Editorial

References (6)

1. Healy D, Cattell D. 2003. Interface between authorship, industry and science in the domain of therapeutics. British Journalof Psychiatry [Internet], Jul 1 [cited 2011 Feb 2]; 183(1), 22-27. Available from: http://bjp. rcpsych. org/cgi/content/abstract/183/1/22.
2. Jureidini, J. N., McHenry, L. B., & Mansfield, P. R. 2008. Clinical trials and drug promotion: Selective reporting of study 329. Intern Journ Risk and Safety in Medicine, 20(1-2), 73-81.
3. Lacasse JR, Leo J. 2010. Ghostwriting at elite academic medical centers in the United States. PLoS Medicine [Internet], Feb 2; 7(2), e1000230. Available from: http://www. plosmedicine. org/article/info%3Adoi%2F10. 1371%2Fjournal. pmed. 10002.
4. Matheson, A. 2011. How industry uses the ICMJE guidelines to manipulate authorship-and how they should be revised. PLoS Medicine [Internet], 8(8), e1001072. doi: 10. 1371/journal. pmed. 1001072. Available from: http://www. plosmedicine. org/article/info%3Adoi%2F10. 1371%2Fjournal. pmed. 1001072.
5. Moffatt B, Elliott C. 2007. Ghost marketing: Pharmaceutical companies and ghostwritten journal articles. Perspectives inBiology andMedicine [Internet], [cited 2011 Feb 2]; 50(1), 18-31. Available from: http://www. webcitation. org/5wJIVyU8j.
6. Sismondo S. 2007. Ghost management: How much of the medical literature is shaped behind the scenes by the pharmaceutical industry? PLoS Medicine [Internet]. Sep [cited 2011 Feb 2]; 4(9), e286. Available from: http://dx. doi. org/10. 1371/journal. pmed. 0040286.